Your browser doesn't support javascript.
loading
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
Le Compte, Maxim; De La Hoz, Edgar Cardenas; Peeters, Sofía; Fortes, Felicia Rodrigues; Hermans, Christophe; Domen, Andreas; Smits, Evelien; Lardon, Filip; Vandamme, Timon; Lin, Abraham; Vanlanduit, Steve; Roeyen, Geert; Van Laere, Steven; Prenen, Hans; Peeters, Marc; Deben, Christophe.
Afiliación
  • Le Compte M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • De La Hoz EC; Industrial Vision Lab, University of Antwerp, Antwerp, Belgium.
  • Peeters S; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Fortes FR; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Hermans C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Domen A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Smits E; Department of Oncology, Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital, Antwerp, Belgium.
  • Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Vandamme T; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium.
  • Lin A; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Vanlanduit S; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Roeyen G; Department of Oncology, Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital, Antwerp, Belgium.
  • Van Laere S; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
  • Prenen H; Plasma Lab for Applications in Sustainability and Medicine ANTwerp (PLASMANT), University of Antwerp, Antwerp, Belgium.
  • Peeters M; Industrial Vision Lab, University of Antwerp, Antwerp, Belgium.
  • Deben C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
NPJ Precis Oncol ; 7(1): 128, 2023 Dec 08.
Article en En | MEDLINE | ID: mdl-38066116
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article